The Power Challenge in Next-Generation Diabetes Technology

The artificial pancreas, often referred to as a closed-loop insulin delivery system, represents one of the most significant advances in type 1 diabetes management. These devices combine a continuous glucose monitor (CGM), an insulin pump, and a control algorithm to automatically adjust insulin delivery based on real-time blood sugar readings. For individuals living with diabetes, this technology promises to reduce the burden of constant decision-making and improve glycemic control. However, the very feature that makes these systems transformative—continuous, automated operation—creates a fundamental engineering challenge: the device must run reliably at all times, day and night, without interruption.

Unlike smartphones or laptops, which can be powered down or charged during the night, an artificial pancreas must operate around the clock. A power failure, even a brief one, can interrupt insulin delivery or glucose monitoring, leading to dangerous blood sugar fluctuations. This requirement shifts the power source from a simple convenience to a critical safety component. As these systems become smaller, more wearable, and increasingly integrated into daily life, the need for innovative power solutions that can support all-day use without frequent recharging or battery swaps has become a pressing priority for researchers and device manufacturers alike.

Current Power Solutions and Their Limitations

Most commercially available artificial pancreas systems rely on lithium-ion or lithium-polymer rechargeable batteries. These power sources are well-understood and widely used in consumer electronics, offering a reasonable balance between energy density, weight, and cost. However, several intrinsic limitations become apparent when these batteries are deployed in a medical device that must operate continuously.

Battery Size and Form Factor

Lithium-ion batteries suitable for powering both a CGM receiver, a pump motor, and a Bluetooth radio for data transmission typically measure several centimeters across. This bulk imposes constraints on device design. Manufacturers must either build larger devices that accommodate larger batteries or accept shorter run times. For users, this trade-off directly affects comfort, discretion, and wearability. A pump that protrudes noticeably under clothing or feels heavy on the skin can deter consistent use, undermining the very benefits of automated therapy.

Recharging Frequency and User Burden

In practice, many current artificial pancreas devices require recharging every 12 to 24 hours, depending on usage patterns, Bluetooth connectivity strength, and the frequency of insulin delivery. Requiring a user to remember to charge a medical device every day, and to plan around that charging window, reintroduces a form of cognitive burden that the technology aims to eliminate. Nighttime charging can be especially problematic: if the device needs to charge while the user sleeps, that charging session must be safe and cannot interfere with the device's ability to deliver insulin or sound alarms.

Battery Degradation Over Time

Rechargeable lithium-ion batteries lose capacity with each charge cycle. Over a typical two-to-four-year device lifespan, a battery may degrade to 70 or 80 percent of its original capacity, meaning the user experiences progressively shorter run times. This degradation can be accelerated by exposure to body heat, frequent deep discharges, and the constant trickle charging typical of wearable devices. Eventually, the battery must be replaced, often requiring a device return to the manufacturer or a clinic visit—an inconvenience that can interrupt therapy.

Safety Concerns at End of Charge

When a lithium-ion battery approaches depletion, the device must conserve power while still maintaining critical functions. Many systems implement low-power modes that reduce CGM sampling frequency, weaken Bluetooth transmission power, or disable non-essential alarms. While these measures extend run time, they can degrade performance precisely when the user may need the device most—during sleep or when blood sugar is already unstable. A power source that can maintain full functionality throughout its intended use period is therefore not just a convenience but a patient safety requirement.

Innovative Approaches to Powering Artificial Pancreas Devices

Recognizing the limitations of conventional batteries, researchers and engineers are pursuing several novel strategies to power artificial pancreas systems. These approaches aim to reduce or eliminate the need for external charging, shrink device size, and improve reliability for true all-day, every-day use.

1. Energy Harvesting from the Body

Energy harvesting technology captures ambient energy from the user's body or environment and converts it into electrical power. For wearable medical devices, the most promising harvesting methods draw on sources that are naturally and continuously available.

Piezoelectric energy harvesting relies on materials that generate an electrical charge when mechanically stressed. In a wearable context, the movement of walking, arm motion, or even the expansion and contraction of the chest during breathing can be harvested. Researchers have developed flexible piezoelectric films that can be integrated into insulin pump housings or the tubing itself. One study demonstrated that a piezoelectric harvester worn on the upper arm could generate up to 50 microwatts during normal daily activity—enough to power a low-power Bluetooth transmitter and supplement the main battery.

Thermoelectric energy harvesting exploits the temperature difference between the skin (roughly 32–35°C) and the ambient environment. Thermoelectric generators (TEGs) placed against the skin can produce small amounts of electricity whenever that temperature gradient exists. For a person sitting in a room at 22°C, a well-designed TEG can generate several microwatts to a few milliwatts. While these power levels are modest, they can be sufficient to trickle-charge a battery or supercapacitor, extending overall run time between external charges.

Biofuel cells represent a more radical approach: they generate electricity directly from biochemical reactions in the body. Enzymatic fuel cells, for example, can harvest energy from glucose in the interstitial fluid or bloodstream. This concept is particularly elegant for an artificial pancreas because the device already has access to glucose data and could theoretically use the fuel it is also regulating. Early-stage research has shown that glucose biofuel cells can produce power densities in the range of 1 to 100 microwatts per square centimeter of electrode area, with operational lifetimes measured in days to weeks in vivo. Significant hurdles remain in enzyme stability, biocompatibility, and long-term reliability, but the concept continues to attract research funding.

2. Wireless Power Transfer and Remote Charging

Wireless power transfer (WPT) technologies enable devices to be charged without physical connection to a power source. For an artificial pancreas, this could mean charging while the user sleeps, sits at a desk, or even drives, without needing to remove the device or access a charging port.

Resonant inductive coupling is the most mature WPT method. It uses magnetic fields generated by a coil in a charging pad to induce current in a corresponding coil inside the device. This approach already powers many consumer wearables and medical implants. For an artificial pancreas, resonant inductive charging would allow the user to place the device near a bedside mat or a pocket-sized charger for brief periods. Because the coupling is magnetic, there is no electrical contact, eliminating corrosion and ingress points that compromise waterproofing. The main limitation is proximity: the device must be within a few centimeters to a few inches of the transmitter coil, which constrains how freely the user can move while charging.

Far-field wireless power using radio frequency (RF) energy is a more ambitious approach. Transmitters operating in the ISM bands (e.g., 915 MHz or 2.4 GHz) can beam power over distances of several meters. The receiving antenna in the device harvests a portion of that RF energy and rectifies it into DC power. While this technology has been demonstrated for low-power sensors (e.g., RFID tags and environmental monitors), the power levels achievable at meter-scale distances are typically in the microwatt range—insufficient for the milliwatt-level demands of an insulin pump and CGM. However, as devices become more energy-efficient and beamforming techniques improve, RF power transfer could become a viable supplementary source that reduces the frequency of wired charging.

Ultrasonic power transfer uses sound waves to transmit energy through tissue and air. This method is being investigated for deeply implanted medical devices, but it could also apply to wearable systems. Ultrasound can penetrate through metal housings and water (sweat) more effectively than magnetic fields, and it does not require precise coil alignment. Research groups have demonstrated ultrasonic power transfer efficiencies of 10 to 30 percent over distances of several centimeters, generating milliwatts of usable power. For an artificial pancreas, an ultrasonic charger could be worn as a wristband or patch that transmits power through the skin to a receiving element on the pump body.

3. Advanced Battery Chemistries and Storage Technologies

Even with energy harvesting and wireless power, most systems will still require a local energy storage element to buffer power during periods of high demand (e.g., when the pump motor is actively delivering a bolus) or when harvesting conditions are unfavorable. Improving the storage element itself is therefore another critical path.

Solid-state batteries replace the liquid or gel electrolyte found in conventional lithium-ion cells with a solid ceramic or polymer electrolyte. This design offers several advantages for medical wearables: higher energy density (potentially 2–3 times that of lithium-ion), no risk of electrolyte leakage, and a wider operating temperature range. Solid-state batteries are also inherently non-flammable, addressing a safety concern that has led to recalls of some wearable medical devices. Companies such as Ilika and QuantumScape have announced solid-state cells designed specifically for medical implants and wearables, with prototypes demonstrating thousands of charge cycles with minimal capacity loss.

Thin-film batteries are another variant that suits the space-constrained environment of a wearable device. Using vapor deposition techniques, manufacturers can create batteries with thicknesses measured in micrometers. These films can be deposited directly onto the device's circuit board or even onto flexible substrates, allowing the battery to conform to the shape of the housing. While thin-film batteries store less total energy than bulk cells, their form factor allows designers to use available space more efficiently. For an artificial pancreas that must remain small and lightweight, a thin-film battery could be wrapped around a pump motor or layered under a display, maximizing energy storage without increasing footprint.

Supercapacitors offer an alternative to batteries for short-term energy storage. They can deliver high bursts of power very quickly—ideal for the moment when an insulin pump motor starts—and they can be charged and discharged hundreds of thousands of times without degradation. A hybrid energy storage system combining a small supercapacitor for peak loads and a battery for baseline power could extend battery life by reducing the stress of repeated high-current draws. Supercapacitors based on graphene or carbon nanotube electrodes are particularly promising because of their high surface area and fast charge-discharge rates.

4. Power Management and Low-Power Design

Beyond the power source itself, how the device manages and consumes energy is equally important. Significant gains can be achieved through intelligent power management algorithms and component selection.

Adaptive sampling and transmission is one such strategy. Rather than sampling glucose at a fixed high rate (e.g., every minute), the device can dynamically adjust its sampling frequency based on the rate of change of blood sugar. When glucose levels are stable, the CGM may sample every five minutes and transmit data infrequently. When glucose is rising or falling rapidly, the system increases its sampling and transmission rate to provide tighter control. This adaptive approach can reduce average power consumption by 40 to 60 percent without compromising safety.

Sleep modes and wake triggers allow the device to power down non-critical subsystems during periods of low activity. For example, the Bluetooth radio, which is often one of the largest power consumers, can be placed in a deep sleep state between scheduled data transmissions. The CGM sensor, pump controller, and algorithm processor can similarly enter low-power states when not actively needed. A real-time clock and a set of interrupt-driven wake triggers (e.g., an alarm signal or a detected glucose threshold crossing) can bring the device back to full operation within milliseconds. These micro-architectural optimizations cumulatively extend battery life in many modern wearables.

Energy-efficient algorithm implementation also matters. The control algorithm that calculates insulin delivery rates can be implemented in fixed-point arithmetic on a low-power microcontroller rather than on a power-hungry digital signal processor. Researchers have demonstrated that a proportional-integral-derivative (PID) controller or a model predictive control (MPC) algorithm can run on a microcontroller consuming less than 100 microwatts in active mode, while still meeting the real-time requirements of glucose regulation. Selecting components with the right balance of performance and efficiency is a key engineering decision in every artificial pancreas design.

Safety and Regulatory Considerations for Novel Power Systems

Introducing a new power technology into a medical device, especially one that directly controls insulin delivery, requires rigorous safety validation and regulatory approval. The U.S. Food and Drug Administration (FDA) and international bodies such as the International Electrotechnical Commission (IEC) have established standards for medical electrical equipment, including battery safety, electromagnetic compatibility, and risk management.

For energy harvesting systems, the unpredictability of the energy source introduces a new layer of complexity. The device must be designed to function safely even when harvesting conditions are poor—for example, if the user is sedentary for many hours. A system that relies heavily on harvested energy must include a backup energy reserve with sufficient capacity to maintain critical functions for a defined period. The FDA's guidance on rechargeable medical devices requires manufacturers to characterize the device's performance at various states of charge and to ensure that the device provides warnings before any loss of critical function.

For wireless power transfer, safety concerns center on tissue heating and electromagnetic field exposure. Specific absorption rate (SAR) limits must be satisfied to ensure that RF or ultrasonic energy does not cause thermal damage. Inductive charging systems operating at frequencies below 1 MHz typically present minimal risk, but far-field RF systems operating at higher frequencies require careful antenna design and power limiting. The IEC 60601 family of standards provides a framework for testing and validating such systems.

For advanced battery chemistries, flammability and toxicity remain key concerns. Solid-state batteries are inherently safer than liquid electrolyte batteries, but they must still pass rigorous testing for short circuit, overcharge, and puncture conditions. The UN Manual of Tests and Criteria (UN 38.3) is the recognized standard for lithium battery transport safety, and similar testing protocols are being developed for emerging chemistries.

Integration Challenges and System-Level Design

Adopting a novel power source is not simply a matter of swapping one battery for another. The entire device architecture must be designed with the power system in mind.

Thermal management becomes more important when energy harvesting components generate heat or when wireless charging induces eddy currents in nearby metal parts. The device must dissipate any excess heat without raising the skin temperature above safe limits (typically a 4°C rise above ambient for medical devices in contact with skin). Engineers must model the thermal profile of the device under worst-case charging and harvesting conditions and may need to incorporate heat-spreading materials or phase-change elements to manage hotspots.

Water and sweat ingress is a persistent challenge for any wearable. A device that relies on piezoelectric or thermoelectric harvesting may have openings or vents that compromise its IP rating. All energy harvesting and wireless charging components must be sealed against moisture while still allowing the physical phenomena (vibration, temperature gradient, magnetic field) to reach the active elements. This often requires novel encapsulation strategies, such as potting compounds, thin-film barriers, or hermetic enclosures.

Form factor and comfort cannot be sacrificed for power system innovation. A battery that lasts three days but makes the device twice as thick is unlikely to be adopted. Engineers must work in close collaboration with industrial designers and clinical end-users to ensure that power system improvements translate into real-world benefits, not just theoretical gains. User-centered design studies have repeatedly shown that wearability and discretion are top priorities for people living with diabetes, often ranking above battery life in surveys.

Future Perspectives and the Path Forward

The quest for a truly all-day artificial pancreas power source is a multidisciplinary endeavor that spans materials science, electrical engineering, biomedical engineering, and regulatory science. No single technology is likely to provide a complete solution; instead, the most successful systems will integrate multiple approaches in a holistic power architecture.

A plausible near-term scenario for the next generation of devices is a hybrid system combining a small solid-state battery for baseline power, a supercapacitor for peak loads, and an inductive wireless charging system that allows the user to charge the device for 15 to 30 minutes per day while performing other activities. Energy harvesting from body motion or heat could serve as a supplementary top-up, extending the interval between mandatory charging sessions from one day to three or four days.

Longer-term research is exploring more radical concepts. Biofuel cells that draw energy directly from the body's glucose could theoretically provide continuous power for weeks or months without any external charging. Implanted piezoelectric harvesters that capture energy from the beating heart or the movement of skeletal muscles could power fully internal artificial pancreas systems that require no external components at all. While these ideas remain in the laboratory stage, they point toward a future in which the artificial pancreas is truly self-sustaining.

Collaboration between academia, industry, and regulatory agencies will be essential to overcome the remaining hurdles. Organizations such as the JDRF and the American Diabetes Association have funded early-stage research in power systems for diabetes devices, while companies like Medtronic and Insulet continue to push the boundaries of commercial product design. Meanwhile, the FDA has published guidance on the safety and performance expectations for rechargeable medical devices, providing a clear regulatory pathway for innovators.

Ultimately, the success of any power solution will be judged by its impact on patient outcomes. A device that must be recharged every 12 hours but achieves excellent glycemic control may be less appealing than one that runs for three days with slightly less precise control. Finding the right balance between power reliability, device size, user convenience, and clinical performance requires ongoing dialogue with the people who wear these devices every day. The diaTribe Foundation and other patient advocacy groups provide invaluable forums for this exchange, ensuring that the voices of those living with diabetes guide the engineering decisions that shape their treatment.

As the artificial pancreas continues to evolve from a research concept into a mainstream therapy, the power source will remain a defining feature that determines whether the device succeeds or fails in real-world use. With the innovative approaches now under development—from energy harvesting and wireless charging to advanced batteries and intelligent power management—the goal of a truly all-day, hassle-free artificial pancreas is moving within reach. The combination of engineering creativity, rigorous safety testing, and patient-centered design will ultimately deliver on the promise of automated insulin delivery that truly frees people from the constant burden of diabetes management.